The FDA has approved the first all-oral, fixed-duration first-line regimen for treatment of chronic lymphocytic leukemia and ...

First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the combination regimen of Venclexta® (venetoclax) ...

At 33 years old, Kaedi Cecala faced […] ...

After a devastating relapse, Jackline’s child needs a bone marrow transplant in India and the funds to get there ...

A bride left wedding guests stunned and many in tears after revealing that the stem cell donor who saved her life was standing among them. As Kaedi Cecala stood beside her husband, Mikey Cecala, the ...

Skidaway Island resident Bruce Koehler is among early participants seeing clinical blood‑count improvements in a nationwide prevention study ...

Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...

In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how ...

A mum who blamed her lower back pain on sleeping on an old mattress was devastated when she was diagnosed with an aggressive ...

Blood cancer (leukemia) is the most common childhood cancer. Early diagnosis through simple blood tests can save lives, but lack of awareness delays treatment. TheHealthSite.com ...

Decades ago, patients who were diagnosed with acute myeloid leukemia, a rare cancer of the bone marrow and blood, were told there was nothing doctors could do for them. In part due to pioneering ...